indication

Schizophreniform

Competitive landscape

as of 2026-07-01
Competitive set
1
1 approved · 0 pipeline

Projection timeline

actual past → guided future · protection walls overlaid
18 events
2020
2024
2028
2032
2036
2040
today
focal launch window
guided / estimated ↑
actual ↓
focal / guidedapprovallabel expansiontrial readoutcongressnclustered events (click to expand)guided (dashed = directional)competitor patent cliff

Competitive set

resolved drugs with trials in this indication
drugWithdrawn
Risperidone
US-approved 1993 · RISPERDAL
—1 trial
OwnerJanssen, L.P. - Investigator Initiated Studies Program
Protection2042

Market size

prevalence as a range, not a number